IFNB1 and lung carcinoma: Bearing in mind that SARS-CoV-2 primarily targets cells in the respiratory tract [4], we further interrogated whether expression of NSP13 might also suppress IFN-β- and IFN-γ-induced ISG expression in A549 cells, a lung carcinoma cell line susceptible to SARS-CoV-2 infection [17].